Results for tag: "Camptosar"

Camptosar (irinotecan) is a chemotherapy drug used to treat metastatic non-small cell lung cancer (NSCLC). It is a topoisomerase inhibitor, meaning it works by blocking the enzyme topoisomerase I, which is necessary for the replication of cancer cells. Camptosar is typically used in combination with other chemotherapy drugs, such as cisplatin and gemcitabine, to increase the effectiveness of treatment. It is also used to treat colorectal cancer and other types of cancer. Camptosar is manufactured by Pfizer, Inc. and is available in both intravenous and oral formulations. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of metastatic NSCLC. Other companies that produce drugs for the treatment of lung cancer include Bristol-Myers Squibb, Merck & Co., AstraZeneca, and Eli Lilly and Company. Show Less Read more